Evidence map›Paper›PMID 11739235›Full record

ArticleBritish journal of pharmacology2001

Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure.

M D Perloff, L L von Moltke, E Störmer, R I Shader, D J Greenblatt

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in British journal of pharmacology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 165 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Review
  9. Article
  10. Drug Interactions between Antimicrobial and Immunosuppressive Agents in Solid Organ Transplant Recipients.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2021
    Review
  11. Review
  12. Article
  13. Association BetweenFrontiers in pharmacology · 2018
    Article
  14. Review
  15. Review
  16. Association of MDR1 single-nucleotide polymorphisms and haplotype variants with multiple myeloma in Chinese Jiangsu Han population.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  17. MDR1 polymorphisms have an impact on the prognosis of Chinese diffuse large B cell lymphoma patients.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

M D PerloffDepartment of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, 136 Harrison Avenue, Boston, Massachusetts, MA 02111, USA.
L L von Moltke
E Störmer
R I Shader
D J Greenblatt
Tufts University · US

Funding

ZIDOVUDINE &LAMIVUDINE ALONE OR IN COMBINATION ON BODY COMPOSITIONM01RR000054 · NCRR · TUFTS MEDICAL CENTER · PI WANKE, CHRISTINE A · 1985 to 2005
$12.2M
CHRONIC BENZODIAZEPINES: BEHAVIOR AND NEUROCHEMISTRYR01DA005258 · NIDA · TUFTS UNIVERSITY BOSTON · PI GREENBLATT, DAVID J · 1987 to 2005
$1.4M
REGULATION OF CYTOCHROME P4503A ACTIVITY IN THE ELDERLYR01MH058435 · NIMH · TUFTS UNIVERSITY BOSTON · PI VON MOLTKE, LISA L · 2001 to 2004
$951k
Metabolic Consequences of HAART: CYP3A and P-gpR01DK058496 · NIDDK · TUFTS UNIVERSITY BOSTON · PI GREENBLATT, DAVID J · 2001 to 2003
$791k
ANTIRETROVIRAL THERAPIES AND SUBSTANCE ABUSER21DA013209 · NIDA · TUFTS UNIVERSITY BOSTON · PI GREENBLATT, DAVID J · 2000 to 2002
$501k
RISKS AND BENEFITS OF HYPONOTIC DRUG THERAPYR37MH034223 · NIMH · TUFTS UNIVERSITY BOSTON · PI SHADER, RICHARD I · 1989 to 1998
–
RISKS AND BENEFITS OF HYPONOTIC DRUG THERAPYR01MH034223 · NIMH · TUFTS UNIVERSITY BOSTON · PI SHADER, RICHARD I · 1985 to 1989
–
PSYCHOTROPIC DRUG METABOLISM IN VITROK21MH001237 · NIMH · TUFTS UNIVERSITY BOSTON · PI VON MOLTKE, LISA L · 1995 to 1999
–
NCRR NIH HHS M01 RR000054NCRR NIH HHS RR-00054NIDA NIH HHS DA-05258NIDA NIH HHS DA-13209NIDA NIH HHS R01 DA005258NIDA NIH HHS R21 DA013209NIDDK NIH HHS DK/AI-58496NIDDK NIH HHS R01 DK058496NIMH NIH HHS MH-01237NIMH NIH HHS MH-34223NIMH NIH HHS MH-58435NIMH NIH HHS R01 MH058435
6 · The paper itself

Abstract

1. Chronic use of Saint John's wort (SJW) has been shown to lower the bioavailability for a variety of co-administered drugs including indinavir, cyclosporin, and digoxin. Decreases in intestinal absorption through induction of the multidrug resistance transporter, P-glycoprotein (P-gp), may explain decreased bioavailability. 2. The present study characterized the response of P-gp to chronic and acute exposure of SJW and hypericin (HYP, a presumed active moiety within SJW) in an in vitro system. Experiments were performed with 3 to 300 microg ml(-1) of methanol-extracted SJW and 0.03 to 3 microM HYP, representing low to high estimates of intestinal concentrations. 3. In induction experiments, LS-180 intestinal carcinoma cells were exposed for 3 days to SJW, HYP, vehicle or a positive control (ritonavir). P-gp was quantified using Western blot analysis. P-gp expression was strongly induced by SJW (400% increase at 300 microg ml(-1)) and by HYP (700% at 3 microM) in a dose-dependent fashion. Cells chronically treated with SJW had decreased accumulation of rhodamine 123, a P-gp substrate, that was reversed with acute verapamil, a P-gp inhibitor. Fluorescence microscopy of intact cells validated these findings. In Caco-2 cell monolayers, SJW and HYP caused moderate inhibition of P-gp-attributed transport at the maximum concentrations tested. 4. SJW and HYP significantly induced P-gp expression at low, clinically relevant concentrations. Similar effects occurring in vivo may explain the decreased bioavailability of P-gp substrate drugs when co-administered with SJW.

Indexed as

HypericumAdenocarcinomaAnthracenesAntidepressive AgentsATP Binding Cassette Transporter, Subfamily B, Member 1Biological Transport, ActiveBlotting, WesternCaco-2 CellsColonic NeoplasmsDose-Response Relationship, DrugDrug InteractionsDrug Resistance, MultipleHumansImage Processing, Computer-AssistedMicroscopy, FluorescencePeryleneAnthracenesAntidepressive AgentsATP Binding Cassette Transporter, Subfamily B, Member 1hypericinPeryleneProtein Kinase CRhodamine 123RitonavirVerapamil

Identifiers

PMID11739235
PMCPMC1572891
OpenAlexW2042128348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.